These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22920049)

  • 41. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compliance with the treatment of hypertension: the potential of combination therapy.
    Erdine S
    J Clin Hypertens (Greenwich); 2010 Jan; 12(1):40-6. PubMed ID: 20047629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension].
    Blacher J; Halimi JM; Hanon O; Mourad JJ; Pathak A; Schnebert B; Girerd X;
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):132-8. PubMed ID: 23743000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Arterial Hypertension - when are which combination therapies useful?].
    Brenner R; Rimoldi SF; Rexhaj E; Allemann Y
    Ther Umsch; 2012 May; 69(5):305-13. PubMed ID: 22547363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations.
    Levi M; Pasqua A; Cricelli I; Cricelli C; Piccinni C; Parretti D; Lapi F
    J Manag Care Spec Pharm; 2016 Mar; 22(3):255-62. PubMed ID: 27003555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker/thiazide diuretics among newly diagnosed hypertensive patients: a population-based cohort study.
    Hsu CI; Hsiao FY; Wu FL; Shen LJ
    Int J Clin Pract; 2015 Jul; 69(7):729-37. PubMed ID: 25395349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combination treatment of hypertension in 2015].
    Špinar J; Vítovec J; Špinarová L; Bendová M
    Vnitr Lek; 2015 May; 61(5):458-65. PubMed ID: 26075856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-Drug Combinations as First-Step Antihypertensive Treatment.
    Mancia G; Rea F; Corrao G; Grassi G
    Circ Res; 2019 Mar; 124(7):1113-1123. PubMed ID: 30920930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.
    Pimenta E; Oparil S
    Vasc Health Risk Manag; 2008; 4(3):653-64. PubMed ID: 18827915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control.
    Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):243-253. PubMed ID: 28608026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and Safety Assessment of Hypertension Management with Coveram (Perindopril/Amlodipine Fixed Combination) in Patients with Previous Angiotensin Receptor Blocker (ARB) Treatment: Arabian Gulf STRONG Study.
    Ahmed M; Alanbaei M; El Tamimi H; Al-Wahshi Y; Al-Zakwani I
    Curr Vasc Pharmacol; 2016; 14(6):570-575. PubMed ID: 27456109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
    Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
    J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).
    Motozato K; Miura S; Shiga Y; Kusumoto T; Adachi S; Inoue T; Fujisawa K; Saku K
    Clin Exp Hypertens; 2016; 38(1):45-50. PubMed ID: 26268636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.